Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer

Not yet recruiting

Registered drugNo placebo

Study of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Camizestrant

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drugNo placebo

A study to evaluate the safety and effectiveness of petosemtamab and pembrolizumab in adults with non-small cell lung cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drugNo placebo

Study of Lorigerlimab and Docetaxel for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drugNo placebo

Study of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drugNo placebo

Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Acute myocardial infarction

Not recruiting

Investigational

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Capecitabine

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drug

Study of INBRX-106 and Pembrolizumab for First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drug

Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Colorectal cancer metastatic+1

Not recruiting

Registered drugNo placebo

Study of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Find therapies in clinical trials near you – page 2

45 trials match your criteria

Breast cancer

Study of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer

Non-small cell lung cancer

A study to evaluate the safety and effectiveness of petosemtamab and pembrolizumab in adults with non-small cell lung cancer

Hormone-refractory prostate cancer+1

Study of Lorigerlimab and Docetaxel for Patients with Metastatic Castration-Resistant Prostate Cancer

Hormone-refractory prostate cancer+1

Study of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer

Breast cancer+2

Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Squamous cell carcinoma of head and neck

A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

Acute myocardial infarction

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

Squamous cell carcinoma of head and neck

Study of INBRX-106 and Pembrolizumab for First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer

Non-small cell lung cancer metastatic

Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Breast cancer+1

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Colorectal cancer metastatic+1

Study of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.